Thorstenson Andreas, Harmenberg Ulrika, Lindblad Per, Holmström Benny, Lundstam Sven, Ljungberg Börje
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, 901 87 Umeå, Sweden ; Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institute, 171 76 Stockholm, Sweden ; Surgical Intervention Trials Unit, Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 7DQ, UK.
Department of Oncology, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden.
Biomed Res Int. 2015;2015:456040. doi: 10.1155/2015/456040. Epub 2015 Oct 11.
Since the start in 2005 virtually all patients with newly diagnosed renal cell carcinoma (RCC) in Sweden are reported to the National Swedish Kidney Cancer Register (NSKCR). The register contains information on histopathology, nuclear grade, clinical stage, preoperative work-up, treatment, recurrence, and survival.
A total of 8556 patients with newly diagnosed RCC were registered in the NSKCR from 2005 to 2013 resulting in a coverage of 99% as compared to the Swedish Cancer Registry. The mean tumor size at detection decreased from 70 mm in 2005 to 64 mm in 2010. The proportion of patients who were incidentally detected increased. The proportion of patients with tumor stage T1a who underwent partial nephrectomy increased from 22% in 2005 to 56% in 2012. Similarly, the proportion of laparoscopically performed radical nephrectomies increased from 6% in 2005 to 17% in 2010. During the five years of follow-up 20% of the patients had a recurrence.
Over the last decade there has been a trend of earlier detection and less advanced tumors at detection in patients with RCC. An increasing proportion of the patients undergo laparoscopic and nephron-sparing procedures.
自2005年开始,瑞典几乎所有新诊断的肾细胞癌(RCC)患者都被报告至瑞典国家肾癌登记处(NSKCR)。该登记处包含有关组织病理学、核分级、临床分期、术前检查、治疗、复发和生存的信息。
2005年至2013年期间,共有8556例新诊断的RCC患者被登记在NSKCR中,与瑞典癌症登记处相比,覆盖率为99%。检测时的平均肿瘤大小从2005年的70毫米降至2010年的64毫米。偶然检测出的患者比例增加。肿瘤分期为T1a的患者接受部分肾切除术的比例从2005年的22%增至2012年的56%。同样,腹腔镜下根治性肾切除术的比例从2005年的6%增至2010年的17%。在五年的随访期间,20%的患者出现复发。
在过去十年中,RCC患者存在早期检测且检测时肿瘤进展程度较低的趋势。越来越多的患者接受腹腔镜手术和保留肾单位手术。